SCHEMBL19650372

SCHEMBL19650372

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2C3C(C[C@H](O)[C@]12C)[C@]1(C)[C@@H](C[C@H](O)C[C@H]1O)C[C@H]3O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 7/20 0.78
CYP3A4 P08684 4/20 0.78
NR1H4 Q96RI1 4/20 0.78
PDE3A Q14432 2/20 0.78
LMNA P02545 2/20 0.71
ABCB11 O95342 3/20 0.64
TDP1 Q9NUW8 2/20 0.63
ALDH1A1 P00352 1/20 0.63
KMT2A Q03164 4/20 0.62
MEN1 O00255 3/20 0.62
SLCO1B3 Q9NPD5 1/20 0.62
SLCO1B1 Q9Y6L6 1/20 0.62
USP2 O75604 1/20 0.62
SLC10A2 Q12908 3/20 0.61
CYP2C19 P33261 1/20 0.61
CHRM2 P08172 1/20 0.61
ADRA2A P08913 1/20 0.61
ADRA1A P35348 1/20 0.61
ENPP2 Q13822 1/20 0.61
SLC10A1 Q14973 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1147290 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL16241720 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL29459591 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL1492131 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL1654286 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL16252975 1.00 GPBAR1 (0.78) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL16057839 0.93 GPBAR1 (0.74) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL18424160 0.93 GPBAR1 (0.74) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL759713 0.91 GPBAR1 (0.71) GPBAR1CYP3A4NR1H4PDE3ALMNA
SCHEMBL4431263 0.90 GPBAR1 (0.70) GPBAR1CYP3A4NR1H4PDE3ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2758060-B1 ROR GAMMA MODULATORS FOR TREATING DIABETES II COMPLICATIONS ETH Zürich (CH) 2017-11-29 EP disclosed